Drug Retention in Spondyloarthritis Varies With Socioeconomic Status

WEDNESDAY, Aug. 25, 2026-- For patients with psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), biologic/targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD) retention varies with countries' socioeconomic status...